Literature DB >> 10413363

Effect of beta-chemokines on human immunodeficiency virus type 1 replication, binding, uncoating, and CCR5 receptor expression in human monocyte-derived macrophages.

Y Jiang1, P E Jolly.   

Abstract

OBJECTIVES: We examined the effect and time of addition of beta-chemokines on human immunodeficiency virus type 1 (HIV-1) replication, binding, and uncoating in human macrophages and measured CCR5 receptor expression during virus binding and uncoating.
METHODS: Macrophages were treated with beta-chemokines before infection, at infection, or postinfection, and virus replication was determined by p24 antigen level. Binding and uncoating of 35[S]-methionine-labeled HIV-1 was measured. CCR5 expression was determined by flow cytometry.
RESULTS: The beta-chemokines potently inhibited virus replication. The strongest inhibition occurred when cultures were pretreated and maintained with beta-chemokines. Beta-chemokines also caused strong inhibition of viral uncoating and a considerable decrease in CCR5 expression during uncoating.
CONCLUSIONS: CCR5 receptors appear to be internalized and recycled to the cell surfaces during HIV entry. The down-regulation of CCR5 expression by beta-chemokines during virus uncoating probably accounts for the reduction in virus uncoating (entry) and hence in virus replication.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10413363

Source DB:  PubMed          Journal:  J Hum Virol        ISSN: 1090-9508


  6 in total

1.  The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages.

Authors:  S Aquaro; P Menten; S Struyf; P Proost; J Van Damme; E De Clercq; D Schols
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

Review 2.  The macrophage in HIV-1 infection: from activation to deactivation?

Authors:  Georges Herbein; Audrey Varin
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

Review 3.  Macrophage signaling in HIV-1 infection.

Authors:  Georges Herbein; Gabriel Gras; Kashif Aziz Khan; Wasim Abbas
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

4.  Bovine immunodeficiency virus expression in vitro is reduced in the presence of beta-chemokines, MIP-1alpha, MIP-1beta and RANTES.

Authors:  S M Wright; A Mleczko; K S Coats
Journal:  Vet Res Commun       Date:  2002-04       Impact factor: 2.459

5.  A multi-targeted drug candidate with dual anti-HIV and anti-HSV activity.

Authors:  Jan Balzarini; Graciela Andrei; Emanuela Balestra; Dana Huskens; Christophe Vanpouille; Andrea Introini; Sonia Zicari; Sandra Liekens; Robert Snoeck; Antonín Holý; Carlo-Federico Perno; Leonid Margolis; Dominique Schols
Journal:  PLoS Pathog       Date:  2013-07-25       Impact factor: 6.823

6.  A Mucosal Adenovirus Prime/Systemic Envelope Boost Vaccine Regimen Elicits Responses in Cervicovaginal and Alveolar Macrophages of Rhesus Macaques Associated With Delayed SIV Acquisition and B Cell Help.

Authors:  Ruth Hunegnaw; Sabrina Helmold Hait; Gospel Enyindah-Asonye; Mohammad Arif Rahman; Eun-Ju Ko; Christopher J Hogge; Tanya Hoang; Marjorie Robert-Guroff
Journal:  Front Immunol       Date:  2020-09-30       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.